DEFINE
Determining the Effectiveness of an online FeNO-guided asthma management INtervEntion in primary care
Background and trial aims
Around 5.4 million people in the UK receive treatment for asthma. However, although more and more asthma medications are being prescribed each year, numbers of serious asthma attacks are not going down.
To help prevent serious asthma attacks, we need to make sure the right treatments are given to the right people in the right amounts.
The DEFINE study is therefore exploring whether measuring fractional exhaled nitric oxide (FeNO) in GP surgeries can improve management of patients with asthma by helping health care professionals provide a more personalised approach.
Who participated?
Asthma patients aged 12 or older who are registered in GP surgeries in Thames Valley and South Midlands, Wessex, East Midlands, Greater Manchester, West Midlands, North East and North Cumbria, Yorkshire and Humber, North West Coast, North Thames and Luton, Essex and Hertfordshire (former) CRNs. Participants were invited to take part in this trial when they were due for their routine asthma review. Recruitment has now ended, and the trial is in follow-up
Recruitment Total: 2,599
What does the trial involve?
FeNO stands for fractional exhaled nitric oxide. It is measured using a simple breath test.
Nitric oxide is a gas which everyone breathes out. People with inflamed airways breathe out more nitric oxide than people whose airways are not inflamed. These patients are more likely to have an asthma attack if their inflammation remains untreated
FeNO is already measured in patients with severe asthma who are seen in hospital clinics. However, very few GP surgeries routinely use FeNO to help them monitor treatment.
The DEFINE study team have therefore designed an online intervention to support health care professionals and patients with using FeNO during asthma reviews in GP surgeries. As well as providing GP surgeries with FeNO measurement equipment, this intervention also offers the following tools:
- An online training tool to support healthcare professionals in how to measure and interpret FeNO.
- A digital FeNO-guided management algorithm to personalise asthma care.
- Information materials for patients on FeNO and its role in asthma management.
The trials intends to discover over the course of one year whether this intervention helps reduce a patient's risk of having an asthma attack. We have recruited just under 2,600 people with asthma into our study from GP surgeries in Thames Valley, Wessex and East Midlands.
Patients have been randomly sorted into one of two groups. The first group have had their FeNO tested when their asthma is routinely reviewed at their GP surgery; the second group have received usual care at their routine review without FeNO testing.
The video below demonstrates how a FeNO measurement is carried out.
Trial status: Follow-up
Expected end date: 02/10/2025
Contact Details
Email (Oxford team): define@phc.ox.ac.uk
Email (Southampton team): define-rct@uhs.nhs.uk
Please direct any correspondence intended for the Nottingham and Leicester teams to the Oxford email address.
Participant Information Documents
Download the DEFINE Participant Information Sheet:
Partner Organisations
University of Oxford Primary Care Clinical Trials Unit (Lead)
University of Southampton
University of Nottingham
University of Leicester
University of Bristol
OXFORD TRIAL TEAM
-
Louise Jones
Clinical Trial Manager
-
Stephanie Robinson
Clinical Trial Coordinator
-
Joy Rahman
Senior Clinical Trials Manager
Chief Investigator
OXFORD CO-INVESTIGATOR
-
Chris Butler
Professor of Primary Care
External Co-Investigators
Mike Thomas Professor of Primary Care Research, University of Southampton |
Ian Pavord Professor of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford |
Nick Francis Professor of Primary Care Research, University of Southampton |
Matthew Martin Clinical Fellow, Nottingham Respiratory Research Unit, University of Nottingham |
Funding Details
The DEFINE trial is funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference RP-PG-0618-20002).
REC: 22/LO/0139
IRAS: 307116
Registration: ISRCTN 16411887
Related Publications
Santillo, M., Ainsworth, B., Van Velthoven, M.H. et al. Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews. npj Prim. Care Respir. Med. 32, 13 (2022). https://doi.org/10.1038/s41533-022-00272-0